help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muls, E.
Right arrow Articles by De Moor, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muls, E.
Right arrow Articles by De Moor, P.

Journal of Clinical Endocrinology & Metabolism, Vol 55, 459-464, Copyright © 1982 by Endocrine Society


ARTICLES

Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment

E Muls, V Blaton, M Rosseneu, E Lesaffre, G Lamberigts and P De Moor

The serum concentrations of total cholesterol (TC), triglycerides (RG), high density lipoprotein-cholesterol (HDLc), low density lipoprotein- cholesterol (LDLc), and the apolipoproteins (apo) A-I, A-II, and B were measured in 33 hyperthyroid patients before and after treatment. The results were compared with those of healthy controls. Apo A-I, A-II, and B were assayed by immunonephelometry. The serum levels of TC (mean +/- SD, 167 +/- 36 mg/dl, HDLc (40.8 +/- 12 mg/dl), and LDLc (108 +/- 35 mg/dl) were decreased in the untreated hyperthyroid patients compared to both the values after treatment (TC: 215 +/- 54 mg/dl; P less than 0.001; HDLc: 52 +/- 14 mg/dl; P less than 0.001; LDLc: 146 +/- 47 mg/dl; P less than 0.001) and the control values (TC: 206 + 39 mg/dl; P less than 0.001; HDLc: 47.4 +/- 10 mg/dl; P les than 0.01; LDLc: 145 +/- 38 mg/dl; P less than 0.001). TG levels were not statistically different before and after treatment. The apo A-I concentrations (116 +/- 24 mg/dl) were lower before than after treatment (131 +/- 28 mg/dl; P less than 0.01), but they were not statistically different from those in the control group (115 +/- 19 mg/dl). The apo A-II levels were identical in all groups (before treatment, 35 +/- 7 mg/dl; after treatment, 37 +/- 9 mg/dl; control group, 36 +/- 9 mg/dl). The apo B levels were lower in the untreated hyperthyroid patients (86 +/- 23 mg/dl) compared to those in controls (103 +/- 19 mg/dl; P less than 0.001) and patients after therapy (103 +/- 25 mg/dl; P less than 0.001). The increase in HDLc relative to the major HDL apo A-I and A-II during treatment for hyperthyroidism was associated with changes in body weight. The apo A-I to apo A-II and LDLc to apo B ratios, however, were significantly lower before compared to those after treatment, when the influence of increasing body weight during therapy was accounted for. This study emphasizes the important regulating role of thyroid hormones on lipid and apolipoprotein metabolism.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. M. Diekman, N. Anghelescu, E. Endert, O. Bakker, and W. M. Wiersinga
Changes in Plasma Low-Density Lipoprotein (LDL)- and High-Density Lipoprotein Cholesterol in Hypo- and Hyperthyroid Patients Are Related to Changes in Free Thyroxine, Not to Polymorphisms in LDL Receptor or Cholesterol Ester Transfer Protein Genes
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1857 - 1862.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Bülow, L. Hagmar, J. Eskilsson, and E. M. Erfurth
Hypopituitary Females Have a High Incidence of Cardiovascular Morbidity and an Increased Prevalence of Cardiovascular Risk Factors
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 574 - 584.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung.
Effect of Thyroid Dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2921 - 2924.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung
Plasma Cholesteryl Ester Transfer Protein Activity in Hyper- and Hypothyroidism
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 140 - 143.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Blangero, S. Williams-Blangero, M. C. Mahaney, A. G. Comuzzie, J. E. Hixson, P. B. Samollow, R. M. Sharp, M. P. Stern, and J. W. MacCluer
Effects of a Major Gene for Apolipoprotein A-I Concentration Are Thyroid Hormone Dependent in Mexican Americans
Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1177 - 1183.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. G. Comuzzie, J. Blangero, M. C. Mahaney, R. M. Sharp, J. L. VandeBerg, M. P. Stern, and J. W. MacCluer
Triiodothyronine Exerts a Major Pleiotropic Effect on Reverse Cholesterol Transport Phenotypes
Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 289 - 293.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society